| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.53 | 0.0009 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |